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ABSTRACT 
 The Indonesian elderly population has been projected to increase up to about four-fold in 
three decades (1990-2020). As a consequence of this population trend, the increased prevalence of 
degenerative diseases would be inevitable; this would include the prevalence of peripheral arterial 
disease. 
This study aims to identify the correlation of diverse risk factors, either traditional or non-
traditional, with the ankle-brachial index scores, and the correlation of novel non-traditional risk 
factor, e.i. high sensitive C-reactive protein with the prevalence of perioheral arterial disease in the 
elderly, age 60-80 years old, with type 2 diabetes mellitus. 
Among the 146 elderly patients with type 2 diabetes mellitus, and based on measurement of 
the ABI score,  approximately 30.9% of them had PAD. Some traditional and non-traditional risk 
factors having a significant correlation with the ankle-brachial index score, were age (r = -0.396, p < 
0.001 for right ABI; r = -0.509, p < 0.001 for left ABI), supine systolic blood pressure (r= -0.268, p = 
0.012 for right ABI; r = -0.267, p = 0.013 for left ABI), 2-hour post-prandial blood glucose (r= -
0.252, p = 0.018 for right ABI), and hsCRP  (r = -0.280, p = 0.011 for right ABI; r = -0.402, p < 
0.001 for left ABI); whereas other risk factors like obesity based on waist circumference and BMI, 
non-supine systolic blood pressure, fasting blood glucose, HbA1C, duration of diabetes, plasma lipids 
did not show statistically significant different odd ratios. After linear regression test for risk factors 
having significant correlations with ABI, age and hsCRP were found to influence the ABI scores. 
Based on a case-control study, risk factors which, to some extent, had  statistically significant values 
as risk factors,  include older age (≥ 70 years old; OR = 7.737 [CI = 2.515-23.805]; p < 0.001), 
relatively high supine diastolic blood pressure (≥ 90 mmHg; OR = 6.882 [CI = 0.789-60.060]; p = 
0.048), and high concentration of hsCRP (> 3 mg/L; OR = 4.420 [CI = 1.287-15.181]; p = 0.013). 
Among these statistically significant risk factors, after logistic regression test analysis, only the age of 
the patient appeared to have significant influence on the prevalence of PAD. 
In conclusion, this study demonstrates a negative correlation between hsCRP and ABI score; 
and high levels of hsCRP appeared to be a risk factor for PAD. The age of the patient, however,  
appeared to be  the strongest risk factor for PAD.   
 
Keywords: Peripheral arterial disease, risk facors, elderly patient, type 2 diabetes mellitus,  high-
sensitivity C-reactive protein, ankle-brachial index. 
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INTRODUCTION 
 
Indonesian elderly population was 
projected to increase up to 414% in the 
period of 1990-2020, the most remarkable 
increment in the world1. In the year of 
2000, Indonesia was the fourth-leadimg 
biggest elderly population worldwide after 
China, India, and the USA.2 
         Approximately 12% of the elderly 
population above 65 years were found to 
have peripheral arterial disease (PAD) in 
one study.3 On the other hand, another 
study which used Ankle Brachial Index 
(ABI) score had found the prevalence of 
PAD in the elderly subjects with type 2 
diabetes mellitus (DM) age above 40 years 
old and above 55 years old as 20% and 18-
23% respectively.3    
PAD is characterized by specific 
athero sclerosis marked by the existence of 
atherosclerotic occlusion in the lower 
extremity and accompanied by 
atherothrombotic disease.4 In USA, PAD 
affects about 12 million people and the 
Framingham Heart Study has found 20% 
of people with signs and symptoms of 
PAD suffered from diabetes.4,5 
The risk factors of PAD comprises 
age, gender, smoking status, hypertension, 
hyperlipidemia, DM, and inflammation. 
Some specific markers of atherosclerosis 
that is related to those risk factors can be 
detected in the peripheral blood and 
include homocystein, lipoprotein a (Lp[a]), 
fibrinogen, high sensitivity C-reactive 
protein (hs-CRP), soluble Fas, VCAM-1, 
ADMA and plasminogen activator 
inhibitor (PAI).6,7,8,9 
High sensitivity C-reactive protein 
is one of the acute phase protein produced 
by the liver, mainly the hepatocytes and in 
the human is so-called calcium-dependent 
ligand binding protein because of the high 
affinity of this protein to bind with the 
phosphocholine (PC) residual. hs-CRP 
would also aggregate the structure which 
possess any relation with the ligand. The 
primary effect resulting from the binding of 
hs-CRP with its ligand is the recognition 
by C1q? and subsequent activation of 
classical complement pathway, C3, 
adhesion molecule, and finally membrane 
attack complex. Binding of hsCRP with its 
ligand is also part of the host defence 
mechanism (against infection) and reacts to 
autologous antigen (whether physiologically 
or pathophysiologically) as the secondary 
effects. hs-CRP is also able to prevent 
autoimmunity.10,11,12 The premise of this 
study is that high concentration of hs-CRP 
would be useful to predict the risk of 
peripheral arterial disease in the elderly with 
type 2 diabetes mellitus.  
 
MATERIALS AND METHODS 
 
The subjects used in this study  were 
recruited from patients attending the 
Geriatric Polyclinic Sanglah General 
Hospital of Denpasar in 2008. 
Design of the research is case 
control study to identify whether elevation 
of high sensitive C-reactive protein is a risk 
factor for the prevalence of PAD in the 
elderly with type 2 DM. 
Every geriatric patients undergoing 
treatment program at the Geriatric Polyclinic 
Sanglah General Hospital Denpasar are 
included as the population of this study. 
The subjects of this study were 
elderly patients aged 60 to 80 years old with 
type 2 DM and undergoing treatment at 
Geriatric Polyclinic Sanglah General 
Hospital Denpasar. Calculated minimal 
subjects required for statistical analysis were 
58 people, however every subject who met 
the age-criteria were also recruited in the 
study.  
 
 
Research Hypothesis 
¾ There is a correlation between ABI 
score and hs-CRP variable in the 
elderly population suffering from type 
2 diabetes mellitus.  
¾ In the elderly with type 2 diabetes 
mellitus, hs-CRP concentration is 
higher in patients with PAD as 
compared to those without PAD.  
Place and Time of Research 
- Geriatric Polyclinic Sanglah General 
Hospital Denpasar, 2008. 
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Population 
- Targeted population : every type 2 diabetic 
elderly patients (age ≥ 60 years old) 
visiting the Polyclinic at Sanglah General 
Hospital of Denpasar.  
- Reachable population : elderly patients 
with type 2 DM age 60 to 80 years old 
whose able to be evaluated by using ABI 
and visiting the Geriatric Polyclinic. 
- Targeted Population : elderly patients with 
type 2 DM age 60 to 80 years old and 
suffering from PAD.  
Sampling (intended sampling) : 
consecutive sampling of population with 
inclusion and exclusion criteria.  
 
Case and Control 
- Case : elderly patients with type 2 
DM (age 60 to 80 years old) suffering 
from PAD as evaluated using ABI 
score (less than 0.9). 
- Control : elderly patients with type 
2 DM (age 60 to 80 years old) without 
PAD. 
 
Research Samples 
The number of Case Control Samples 
By using the related formula as listed 
below : 
- By Odds Ratio which is estimated at 
about 3.8 with PAD and control group 
ratio > 1, also control plasma hs-CRP 
proportion of 0.4, then the minimal 
sample size required for each groups is 
39, and subsequently rounded to 40. 
  
Inclusion and Exclusion Criteria 
Inclusion Criteria : 
- Elderly patients with type 2 DM age ≥ 
60 years old whose undergoing 
treatment program in Geriatric Clinic 
Sanglah Hospital 
- Willing and agree to participate in the 
study as  subjects by signing the 
informed consent.  
 
 
Exclusion Criteria : 
- Elderly patients (age ≥ 60 years old) 
with acute cardiovascular attack / 
acute coronary syndrome, stroke, acute 
infection / inflammation, acute liver 
function disturbance (SGOT and 
SGPT ≥ 2-fold higher of normal value 
and chronic liver disease / hepatitis 
cirrhosis), neoplastic disease, acute 
kidney failure, and chronic kidney 
disease with creatinine serum > 3 
mg/dL or if CCT score < 60. 
- Technically unable to undergo ABI 
evaluation, for instance patients with 
amputed extremities. 
 
 
Variable Identification and Classification. 
- Independent variables: risk factor, i.e. 
hs-CRP.  
- Dependent variables : effect, i.e. PAD as 
measured using ABI.  
- Control variables : consists of DM, 
hypertension, dyslipidemia, and 
smoking habbit. 
- Confounding variables : consists of 
genetic, coagulation factor, etc, which 
due to many reasons are not evaluated 
in this research. Samples were obtained 
based on consecutive sampling method 
from the targeted population which 
passed the inclusion and exclusion 
criteria.  
 
RESULTS 
Table 1.  Abnormal Prevalence of Various 
PAD  
       Risk Factors in the Elderly with type 
2 DM 
Variables Prevalence 
(%) 
Age (≥ 70 years old) 
Central obesity (waist circumference ≥ 
90 cm for male; ≥80 cm for female) 
Obese according to BMI (≥ 25 kg/m2) 
Lying hypertension (≥ 140/90 mmHg) 
Sitting hypertension (≥ 140/90 mmHg) 
Standing hypertension (≥ 140/90 mmHg) 
High level of total cholesterol (≥ 240 
mg/dl) 
High level of LDL cholesterol (≥ 130  
mg/dl) 
Low level of HDL cholesterol ( <40 
mg/dl for male; <50 mg/dl for female) 
High level of triglycerides (≥ 200 mg/dl) 
Fasting blood glucose with poor control 
(≥ 126 mg/dl) 
2-hour post prandial blood glucose with 
poor control (≥ 180 mg/dl) 
A1C with poor control (≥ 8%) 
31,4 
69,6 
 
42,0 
54,3 
58,6 
52,9 
17,1 
 
42,9 
 
37,1 
 
21,4 
35,7 
 
52,9 
 
32,9 
Data from Perkeni 2006? 
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Table 2. Age Correlation and a Number 
of PAD Risk Factors  
 
Variables 
Age 
r P 
Lying systolic 
blood pressure 
2-hour pp blood 
glucose  
hs-CRP 
0,140 
 
0,059 
 
0,187 
0,125 
 
0,313 
 
0,066 
*Significant. Statistical analysis by using 
Pearson correlation dan Spearman 
correlation. 
 
Table 3. Correlation between Various 
Extent of PAD Risk Factors and ABI 
 
Variables 
Right ABI Left ABI 
r p r p 
 
Age 
Waist circumference  
Body Mass Index 
Lying systolic blood 
pressure 
Sitting systolic blood 
pressure  
Standing systolic 
blood pressure  
Lying diastolic blood 
pressure 
Sitting diastolic blood 
pressure  
Standing diastolic 
blood pressure  
Total cholesterol  
LDL cholesterol 
HDL cholesterol  
Triglycerides 
Fasting blood glucose 
2-hour pp blood 
glucose  
A1C  
Duration of diabetes 
hs-CRP  
 
 
-0,396 
0,106 
0,169 
-0,268 
 
-0,131 
 
-0,179 
 
-0,064 
 
0,144 
 
0,097 
 
-0,104 
-0,164 
-0,130 
0,050 
0,100 
-0,252 
 
0,007 
-0,114 
-0,280 
 
<0,001* 
0,388 
0,082 
0,012* 
 
0,139 
 
0,069 
 
0,299 
 
0,177 
 
0,213 
 
0,195 
0,087 
0,141 
0,340 
0,204 
0,018* 
 
0,477 
0,179 
0,011* 
 
-0,509 
0,054 
0,158 
-0,267 
 
-0,103 
 
-0,193 
 
-0,081 
 
0,096 
 
0,120 
 
-0,012 
0,039 
0,052 
0,094 
0,180 
-0,128 
 
0,010 
-0,173 
-0,402 
 
<0,001* 
0,660 
0,097 
0,013* 
 
0,199 
 
0,054 
 
0,252 
 
0,215 
 
0,161 
 
0,460 
0,376 
0,334 
0,218 
0,068 
0,146 
 
0,469 
0,081 
<0,001* 
 
 
 
*Statistically significant. Statistical 
analysis by using Pearson correlation and 
Spearman correlation. 
 
 
 
 
 
 
 
Case Control Study 
Table 4. Odds Ratio of Various Risk 
Factors to the Contribution of PAD Event  
 
Variables Odds ratio 
95% CI 
Lower-upper p 
Age (60-69 vs. 70-80 years 
old) 
Waist circumference  (normal 
vs. obese) 
Body Mass Index (non-obese 
vs. obese) 
Lying systolic blood pressure 
(normal vs. high) 
Sitting systolic blood pressure 
(normal vs. high) 
Standing systolic blood 
pressure (normal vs. high) 
Lying diastolic blood pressure 
(normal vs. high) 
Sitting diastolic blood 
pressure (normal vs. high) 
Standing diastolic blood 
pressure (normal vs. high) 
Lying hypertension 
Sitting hypertension 
Standing hypertension 
Total cholesterol  (normal vs. 
high) 
LDL cholesterol  (normal vs. 
high) 
HDL cholesterol (normal vs. 
low) 
Triglycerides  (normal vs. 
high) 
Fasting blood glucose  
(normal vs. high) 
2-hour pp blood glucose  
(normal vs. high) 
A1C  (normal vs. high) 
Duration of diabetes  (<5 vs. 
≥5 years) 
hs-CRP (normal vs. high) 
7,737 
 
0,890 
 
1,000 
 
1,842 
 
0,902 
 
1,224 
 
6,882 
 
2,616 
 
2,250 
 
2,053 
1,111 
1,357 
1,000 
 
2,037 
 
1,000 
 
0,333 
 
0,722 
 
1,353 
 
0,704 
2,087 
 
4,420 
2,515-23,805 
 
0,346-2,293 
 
0,394-2,540 
 
0,755-4,493 
 
0,270-2,198 
 
0,507-2,957 
 
0,789-60,060 
 
0,625-10,950 
 
0,619-8,184 
 
0,836-5,041 
0,452-2,733 
0,559-3,292 
0,316-3,189 
 
0,834-4,976 
 
0,399-2,506 
 
0,105-1,059 
 
0,289-1,804 
 
0,560-3,26 
 
0,272-1,823 
0,800-5,444 
 
1,287-15,181 
<0,001 
 
0,809 
 
1,000 
 
0,178 
 
0,820 
 
0,653 
 
0,048 
 
0,176 
 
0,210 
 
0,115 
0,818 
0,499 
1,000 
 
0,116 
 
1,000 
 
0,056 
 
0,485 
 
0,501 
 
0,469 
0,130 
 
0,013 
 
- From 146 elderly patients suffering 
from type 2 DM, the PAD prevalence 
are:  
› Prevalence = 30.8%. 
› Age 60-69 : 70 years old above = 
20.79% : 48.89% (p = 0.001).  
› There are no differences based on 
gender. 
Correlation of Several PAD Risk Factors 
with ABI 
- Based on this research : there is 
negative correlation between ABI score 
and age, lying SBP, 2-hour pp blood 
glucose concentration, and hs-CRP.  
- In this research, ABI score yields the 
firmest correlation with age (r = -0.509; 
p < 0.001), and hs-CRP (r = -0.402; p < 
0.001).  
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Correlation of Age with Several PAD 
Risk Factors. 
- After correlation test among various 
PAD risk factors and ABI (left and 
right): there is correlation between 
ABI and age, lying SBP, 2-hour pp 
blood glucose concentration (only with 
right ABI), and hs-CRP. 
- Lying SBP and hs-CRP also influences 
ABI score in elderly with type 2 DM. 
 
Odds ratio of Various Risk Factors and 
its Contribution to the Development of 
PAD. 
- In this research, the extent of risk 
(odds ratio [OR]), i.e. several PAD 
traditional and non-traditional risk 
factors which contribute to the event of 
PAD are examined. 
- 40 cases of PAD and 40 cases without 
PAD (control) whose fulfilled the 
overall patient criteria as had been 
examined in the beginning of the 
research have been analyzed. 
-  From the result of this research, 
among great extents of risk factors 
which have been observed and 
statistically significant as risk factors 
consist of: older age (≥ 70 years old; 
OR = 7.737 [CI = 2.515-23.805]; p < 
0.001), highly lying DBP (≥ 90 
mmHg; OR =6.882 [CI = 0.789-
60.060]; p = 0.048), and high 
concentration level of hs-CRP (> 3 
mg/L; OR = 4.420 [CI = 1.287-
15.181]; p = 0.013). 
- Another risk factors analyzed in this 
research do not demonstrate 
statistically different ORs. 
 
DISCUSSION 
 
Peripheral Arterial Disease 
 Peripheral arterial disease is a 
specific illness marked by atherosclerosis 
with arterial occlusion on the lower 
extremities, whereby this is one of 
macroangiopathy state in diabetes 
mellitus.3,13 The most common symptom 
arises from PAD is called intermittent 
claudication, which characterized by pain 
and paralysis of metatarsal and lower 
extremities. These symptoms become more 
prominent while walking or during activities 
(walking history) and diminish after a period 
of rest. In a severe form of PAD or stage 4, 
those symptoms will strongly expressed 
during rest period and even accompanied 
with the presence of gangrene.3,5,14  
 
Atherosclerosis as a basic pathology in the 
Pathogenesis of Peripheral Arterial Disease  
 Atherosclerosis underlies the 
peripheral arterial disease, stroke, coronary 
artery disease, and aortic aneurysm. One of 
the developmental processes of 
atherosclerosis is response to injury. During 
normal condition, endothelial cells which 
lining up the tunica intima form a permeable 
barrier to regulate the influx of plasma 
substances into arterial wall. Damage to 
these endothelial cells, either small or 
relatively large would change the 
permeability characteristics and ability of 
these cells to bind one another with the 
connective tissues beneath.8,15 
 
Peripheral Arterial Disease and its 
Correlation with hs-CRP 
 High sensitive C-Reactive Protein 
(hs-CRP) is a form of an acute phase 
protein. CRP belongs to pentraxin family, a 
plasma protein which binds to its ligand. 
Human CRP molecule (Mr 115.135) consists 
of five identical non-glycosilated 
polypeptide subunit (Mr 23.027), each 
contains 206 amino acids residues.16 
 hs-CRP has the highest binding 
affinity on the phosphocholine residues17. 
However, it also binds to a variety of 
autologous and extrinsic (nuclear 
ribonucleoprotein and apoptotic cell) ligand. 
Extrinsic ligand (phospholipid, fungi, 
parasites) when aggregating with 
macromolecule ligand is recognized by C1q. 
This would activate the classical 
complement pathway, binds to C3 (adhesion 
molecule on complement system) and 
membrane attack complex terminal, C5-C9. 
As soon as after hs-CRP binds to its ligands, 
it owns a broad secondary effects, i.e. 
initiation, opsonization, phagocytosis, and 
lysis of cell as a response to inflammation.18 
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 hs-CRP has been extensively 
correlated with the severity of 
atherosclerosis, whereas it also able to 
predict the cardiovascular event on whether 
or not cardiovascular disease-free 
individuals. The increased concentration 
level of inflammatory mediators can depict 
the inflammation happened in the arterial 
wall (which is related to atherosclerosis) 
and may also directly involved in the 
disease process. Obviously, from the 
pathological perspective, atherosclerosis is 
correlated with cytokines and typical cells 
responsible for inflammation. Similar to 
the previous studies, hs-CRP tends to 
increase on patients with 
atherosclerosis.19,20 
 
The Effects of hs-CRP Concentration in 
Elderly 
 There has been a relatively few 
data or researches regarding the 
measurement of hs-CRP concentration in 
elderly as a specific population study. One 
of those is the study conducted by Maija 
Hassinen et al. (2006) in Finland among 
103 elderly women age 60 to 70 years old 
in 1991. After undergoing follow-up 
procedure for 12 years, a striking result 
was revealed. Even a little increment of hs-
CRP concentration would increase the 
propensity of elderly women to suffer 
metabolic syndrome (i.e. obesity, insulin 
resistance, dyslipidemia, increased of blood 
pressure, and endothelial dysfunction) 
approximately 5 to 6-fold higher in the 
future, when compared with those who 
experienced a decrease in hs-CRP 
concentration.21,22,23  
 
hs-CRP Concentration Measurement 
 High-sensitivity test procedure in 
response of measuring the CRP 
concentration is recommended for people 
who would like to identify quantitatively 
the risk of cardiovascular disease. To 
memorize this issue, the CRP terminology 
that is frequently used by doctor is hs-
CRP.15,24 
 During the usage of hs-CRP as one 
of the risk factors of cardiovascular 
disease, it is classified into three different 
groups based on the classification of the 
American Heart Association (AHA) and the 
Centers for Disease Control and Prevention 
(CDC), i.e.: Low risk: <1.0 mg/L; Average 
risk: 1.0-3.0 mg/L; High risk: >3.0 mg/L 
(API, 2005). 
 
hs-CRP Level and Peripheral Arterial 
Disease in Elderly with DM 
 Diabetes mellitus can directly 
involves in the mechanism of atherosclerosis 
which underlies the pathogenesis of PAD.25 
Hiperglycemia and insulin resistance 
implicates in endothelial dysfunction on type 
2 DM. Another conceivable-related factors 
comprise the increase of oxidative stress and 
lipid involvement, which are still argued for 
its role.3 
 Peripheral Arterial Disease has 
become a major cause of morbidity for 
elderly living in the USA. The incidence of 
PAD is reaching up 26.6 per 1000 male and 
13.3 per 1000 female age above 65 years 
old. Prevalence of PAD is about 10% in 
general population age above 55 years old. 
Data obtained from The Framingham Heart 
Study demonstrates the co-existence of 
symptomatic PAD in diabetic patients for 
approximately 20% of study population.3 
Inflammation has been recognized not only 
as a marker but also for its probability of 
becoming the risk factor of PAD in diabetes. 
The increase of hs-CRP is firmly correlated 
with the occurence of PAD in diabetic 
patients.3 However, this issue was unable to 
be proved in this study. The results are: there 
is no significant difference of hs-CRP mean 
concentration (p = 0.869) between PAD and 
non-PAD patients. The result of analysis 
demonstrates an elevated risk of getting 
PAD to 2-fold higher in accord with 
elevation of hs-CRP concentration (cut point 
1 mg/L) on elderly with diabetes mellitus, 
yet it possessed an insignificant statistical 
power (p = .205). Despite both results were 
insignificant, the elevation of hs-CRP with 
cut point of 1 mg/L seems to have better 
accuracy in estimating the event of PAD on 
elderly with DM when compared to cut 
point of 3 mg/L. This is probably as a result 
of sample inadequacy to fulfill the statistical 
analysis criteria or might be due to the 
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relatively weak internal correlation 
between those variables itself. 
 
Novelty 
 The study regarding the role of 
new PAD risk factors (i.e. non-
traditional) in elderly with type 2 DM 
is rarely conducted, whereas there has 
been no similar research had been 
performed in Indonesia. 
 Based on assumption of any 
differences in other population, 
including race and geographical 
factors, thus the research related to the 
role of several non-traditional risk 
factors that is linked to the 
development of PAD is observed here. 
To date, there has been no study able 
to found any correlation between risk 
factors that comprehensively 
contribute to the event of PAD. 
 This research found, apart of 
traditional risk factors, i.e. age, blood 
pressure, and blood glucose 
concentration, it is worthy to note the 
role of newly discovered risk factors, 
hs-CRP and its role on the 
development of PAD in elderly 
patients with type 2 DM.  
 A sum of correlations between 
various risk factors in elderly with 
type 2 DM and its role to the 
development of PAD has been 
determined.  
 
Study Limitations 
- Methodological aspect. 
- The pathogenesis of PAD is relatively 
complex which involves various 
contributions of risk factors. 
- Knowledge aspect. 
-  The pathogenesis of PAD is relatively 
complex with no single risk factor 
which has been proven to be the direct 
causal of PAD development. 
- In this research, the extent of risk 
(odds ratio [OR]), i.e. several PAD 
traditional and non-traditional risk 
factors which contribute to the event of 
PAD are examined. 
- 40 cases of PAD and 40 cases without 
PAD (control) whose fulfilled the 
overall patient criteria as had been 
examined in the beginning of the 
research have been analyzed. 
- From the result of this research, among 
great extents of risk factors which have 
been observed and statistically 
significant as risk factors consist of: 
older age (≥ 70 years old; OR = 7.737 
[CI = 2.515-23.805]; p < 0.001), highly 
lying DBP (≥ 90 mmHg; OR =6.882 [CI 
= 0.789-60.060]; p = 0.048), and high 
concentration level of hs-CRP (> 3 
mg/L; OR = 4.420 [CI = 1.287-15.181]; 
p = 0.013). 
- Another risk factors analyzed in this 
research do not demonstrate statistically 
different ORs. 
 
CONCLUSIONS AND 
RECOMENDATIONS 
 
Conclusions 
 A negative correlation between hs-
CRP and ABI score has been found .  
 A highly level of hs-CRP 
concentration is a risk factor (4.4-fold 
higher when compared with normal 
concentration) to the development of 
PAD. 
 Important discoveries can be 
concluded i.e.: age (mainly for those ≥ 
70 years old) is the most essential risk 
factor and truly consistent to the 
development of PAD. On the other 
hand, hypertension and blood glucose 
concentration are both weak traditional 
risk factors and become the most 
inconsistent risk factors of PAD on this 
research. 
 
Recommendations 
- Further studies are required to reveal 
another novel risk factors which possess 
an important role in the pathogenesis of 
PAD. 
- PAD is the easiest diagnosed-form of 
atherosclerosis event which is able to 
predict another more fatal 
cardiovascular events (e.g. coronary 
heart disease and stroke).  
- Knowledges about essential PAD risk 
factors among our population (Bali in 
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particular and Indonesia in general) in 
turn, become more important when 
related to prevention and treatment. 
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